Frontline plc.
FRO – 2024 Annual General Meeting
FRO – 2024 Annual General Meeting
Frontline plc (the “Company”) advises that the 2024 Annual General Meeting of the Shareholders of the Company was held on 12 December 2024 at 09:00 a.m. at Metis Tower, 28th October Avenue and Iakovou Tombazi Street, 4th floor, 3107 Limassol, Cyprus. The audited consolidated financial statements for the Company for the year ended 31 December 2023 were presented to the Meeting.
In addition, the following resolutions were passed:
- To re-elect John Fredriksen as a Director of the Company.
- To re-elect James O’Shaughnessy as a Director of the Company.
- To re-elect Ola Lorentzon as a Director of the Company.
- To re-elect Cato Stonex as a Director of the Company.
- To re-elect Steen Jakobsen as a Director of the Company.
- To elect Ørjan Svanevik as a Director of the Company.
- To elect Dr. Maria Papakokkinou as a Director of the Company.
- To re-appoint PricewaterhouseCoopers of Limassol, Cyprus as auditors and to authorise the Directors to determine their remuneration.
- To approve the remuneration of the Company’s Board of Directors of a total amount of fees not to exceed USD 600,000 for the year ended December 31, 2024.
- To approve with effect from 12:00 p.m. (Cyprus time) on 12th December, 2024 (the “Effective Date”) and for a period of twelve (12) calendar months from the Effective Date the exclusion of the shareholders’ right of pre-emption with respect to any offer by the Company to the public against cash consideration, as may be decided by the Board of Directors from time to time, of a maximum of 377,377,111 ordinary shares of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company at a subscription price which shall be determined by the Board of Directors not lower than USD 1 per share.
- To approve with effect from 12:00 pm (Cyprus time) on 12th December, 2024 (the “Effective Date”) and for a period of twelve (12) calendar months from the Effective Date the exclusion of the shareholders’ right of pre-emption with respect to any offer by the Company to the public for cash consideration as may be decided by the Board of Directors from time to time, of a maximum of 377,377,111 debentures or other securities convertible into ordinary shares of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company or options or other securities carrying the right to subscribe for ordinary shares of the Company of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company at a subscription price which shall be determined by the Board of Directors not lower than USD 1 per security.
- To approve on an advisory vote basis the Company’s Remuneration Report for the year ended December 31st, 2023 pursuant to the provisions of the Encouragement of Long-Term Shareholders Engagement Law 111(I)/2021.
12 December 2024
The Board of Directors
Frontline plc
Limassol, Cyprus
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Bitget Limited26.12.2024 16:46:34 CET | Press release
Bitget to Merge BGB and BWB Tokens, Advancing a Unified Onchain Ecosystem
Zealand Pharma25.12.2024 17:40:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma25.12.2024 17:30:00 CET | Press release
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
VERUM MESSENGER LTD25.12.2024 09:00:00 CET | Press release
Verum Ecosystem: The Future of Digital Communication and Finance
Made In Nature24.12.2024 22:54:25 CET | Pressemeddelelse
Made in Nature, økologiske gaver under juletræet: En kærlig gestus over for mennesker og planeten
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom